Advertisement

Topics

Tissue Regenix Introduces Revolutionary dCELL® Platform Technology to the United States

09:03 EST 23 Feb 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Company’s patented platform technology addresses critical clinical needs in regenerative medicine Tissue Regenix, the U.K.-based leader in regenerative medicine, has established its decellularization (dCELL®) Techn...

Other Sources for this Article

Tissue Regenix
Jeff Stoecker, 617-624-3424
TissueRegenix@racepointglobal.com

NEXT ARTICLE

More From BioPortfolio on "Tissue Regenix Introduces Revolutionary dCELL® Platform Technology to the United States"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Wound management
Anything that breaks the skin is a wound because when the skin is broken, there's a risk of germs getting into the body and causing an infection. Follow and track Wound Care News on BioPortfolio: Wound Car...